Results 181 to 190 of about 34,912 (203)

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy.

open access: yesBlood
Chappell ME   +26 more
europepmc   +1 more source

Molecular Basis of α-Thalassemia in Iran [PDF]

open access: yesIran Biomed J, 2018
Valaei A   +3 more
europepmc   +1 more source

Rapid and simultaneous detection of β- thalassemia point mutations by reverse hybridization strip assay among Egyptian patients

Journal of Biochemistry, Microbiology and Biotechnology, 2016
Thalassemia is a wide range hereditary disease with high incidence in Egypt along with the high frequency of consanguineous marriages. Investigation the heterogeneity, molecular basis, and natural history are the most effective methods to deal with the thalassemia to develop effective method for management and prevention including the prenatal ...
Osama Shalaan   +3 more
openaire   +1 more source

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

New England Journal of Medicine, 2021
David M Altshuler   +2 more
exaly  

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

New England Journal of Medicine, 2020
Maria Domenica Cappellini   +2 more
exaly  

β-Thalassemia

New England Journal of Medicine, 2005
Deborah Rund
exaly  

Survival in Medically Treated Patients with Homozygous β-Thalassemia

New England Journal of Medicine, 1994
Nancy F Olivieri, Alan R Cohen
exaly  

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

New England Journal of Medicine, 2018
Alexis A Thompson   +2 more
exaly  

Bone Marrow Transplantation in Patients with Thalassemia

New England Journal of Medicine, 1990
Emanuele Angelucci, Donatella Baronciani
exaly  

Home - About - Disclaimer - Privacy